Heron Therapeutics (HRTX) Assets: 2010-2025
Historic Assets for Heron Therapeutics (HRTX) over the last 13 years, with Sep 2025 value amounting to $248.9 million.
- Heron Therapeutics' Assets rose 12.76% to $248.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $248.9 million, marking a year-over-year increase of 12.76%. This contributed to the annual value of $233.1 million for FY2024, which is 4.78% up from last year.
- Latest data reveals that Heron Therapeutics reported Assets of $248.9 million as of Q3 2025, which was up 7.26% from $232.1 million recorded in Q2 2025.
- In the past 5 years, Heron Therapeutics' Assets ranged from a high of $404.2 million in Q2 2021 and a low of $201.2 million during Q2 2023.
- In the last 3 years, Heron Therapeutics' Assets had a median value of $222.5 million in 2023 and averaged $225.5 million.
- Per our database at Business Quant, Heron Therapeutics' Assets plummeted by 39.65% in 2022 and then rose by 12.76% in 2025.
- Quarterly analysis of 5 years shows Heron Therapeutics' Assets stood at $305.7 million in 2021, then decreased by 17.91% to $251.0 million in 2022, then fell by 11.33% to $222.5 million in 2023, then climbed by 4.78% to $233.1 million in 2024, then climbed by 12.76% to $248.9 million in 2025.
- Its Assets stands at $248.9 million for Q3 2025, versus $232.1 million for Q2 2025 and $235.8 million for Q1 2025.